|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 29, 2016 ) According to a new market research report the Pre-Clinical Imaging (In-VIVO) Market is expected to reach $797 million by 2019, at CAGR of 6.0% from 2014 to 2019.
Preclinical Imaging (in-vivo) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019
Browse 84 market data tables and 65 figures spread through 184 pages and in-depth TOC on "Pre-Clinical Imaging (In-VIVO) Market "
http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market-841.html
Early buyers will receive 10% customization on this report.
Based on modality, the global Pre-Clinical Imaging (In-VIVO) Market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photo acoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and trimodality (PET/SPECT/CT) imaging systems.
Bases on the reagents, the global Pre-Clinical Imaging (In-VIVO) Market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=841
A number of factors such as technological advancements in molecular imaging modalities, rising adoption of multi-modality imaging systems in preclinical research studies, and growing acceptance of preclinical imaging in drug discovery and development processes are fueling the demand of preclinical imaging systems and reagents. On the other hand, declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global Pre-Clinical Imaging (In-VIVO) Market.
As of 2014, North America holds the largest share of the global Pre-Clinical Imaging (In-VIVO) Market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2014 to 2019. A number of factors, including rising R&D activities by big pharma and biotech companies in developing nations, increased government funding for development of pharmaceutical industry, and growing number of CROs in emerging markets are stimulating the growth of the Pre-Clinical Imaging (In-VIVO) Market in the Asia-Pacific region.
Get Report Sample: http://www.marketsandmarkets.com/requestsample.asp?id=841
Aspect Imaging (Israel), Biospace Lab S.A. (France), Bruker Corporation (U.S.), LI-COR Biosciences (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd (U.K.), PerkinElmer, Inc. (U.S.), TriFoil Imaging (U.S.), and FUJIFILM VisualSonics, Inc. (Canada) are the key players operating in the global Pre-Clinical Imaging (In-VIVO) Market.
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
